Ponesimod
CAY-22053-10 10 mg
Data Sheet: 
SDS:
SDS:
CAS
854107-55-4
Formulation
A crystalline solid
Purity
≥98%
MW
461
Shipment
-20
Long Term Storage
-20
Shelf Life
1460
Description
A potent S1P1 receptor agonist (IC50s = 6, >10,000, 2,068, 1,956, and 142 nM for S1P1-S1P5, respectively, in a radioligand binding assay); selectively activates S1P1 in a GTPγS assay (EC50s = 5.7, >10,000, 105, 1,108, 59.1 nM, for S1P1-S1P5, respectively); reduces the number of circulating lymphocytes in rats in a dose-dependent manner; reduces edema, protein extravasation, neutrophil activity, and skin levels of the proinflammatory cytokines IL-1β, IL-6, IFN-γ, and TNF-α in a mouse model of delayed-type hypersensitivity; prevents footpad swelling in a rat model of adjuvant-induced arthritis
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).
